Based on these results and those from our study, we suggest that the infiltration of CD8+CD103+ TILs is also a predictor of very favorable prognoses in patients with pSCC, as well as those with ovarian and bladder cancers. The gene discussed is CD8A; the disease is urinary bladder carcinoma.